logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Tateaki Naito

Shizuoka Cancer Center
H指数:43
被引数:8,112

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of Docetaxel Plus Ramucirumab for Malignant Pleural Effusion and Cerebral Edema in Patients With Advanced Non-Small Cell Lung Cancer: A Single-Institution Retrospective Study

多西他赛联合雷莫芦单抗对晚期非小细胞肺癌患者恶性胸腔积液和脑水肿的疗效：一项单机构回顾性研究

Thoracic Cancer
IF2.3
2026-05-010
OAAI
Morita, Meiko; Wakuda, Kazushige; Matsuda, Suguru; Sekikawa, Motoki; Miura, Keita; Kodama, Hiroaki; Yabe, Michitoshi; Mamesaya, Nobuaki; Kobayashi, Haruki; Ko, Ryo; Ono, Akira; Kenmotsu, Hirotsugu; Naito, Tateaki; Murakami, Haruyasu; Takahashi, Toshiaki
Weight change and impact on prognosis in patients with advanced non-small cell lung cancer with concomitant diabetes mellitus treated with sglt2 inhibitors

晚期非小细胞肺癌合并糖尿病且接受SGLT2抑制剂治疗患者的体重变化及其对预后的影响

Supportive Care in Cancer
IF3
2026-04-280
PRE
Noboru Morikawa; Tateaki Naito; Yuta Okawa; Suguru Matsuda; Meiko Morita; Motoki Sekikawa; Kosei Doshita; Michitoshi Yabe; Hiroaki Kodama; Keita Miura; Yuko Iida; Nobuaki Mamesaya; Haruki Kobayashi; Ryo Ko; Akira Ono; Hirotsugu Kenmotsu; Haruyasu Murakami; Toshiaki Takahashi
Efficacy of Osimertinib in Patients With Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations

奥希替尼对携带敏感EGFR突变且术后复发的非小细胞肺癌患者的疗效

Thoracic Cancer
IF2.3
2026-04-240
OAAI
Iida, Yuko; Kenmotsu, Hirotsugu; Mori, Keita; Morita, Meiko; Sekikawa, Motoki; Yabe, Michitoshi; Doshita, Kosei; Miura, Keita; Kodama, Hiroaki; Morikawa, Noboru; Mamesaya, Nobuaki; Kobayashi, Haruki; Ko, Ryo; Wakuda, Kazushige; Ono, Akira; Naito, Tateaki; Murakami, Haruyasu; Ohde, Yasuhisa; Gon, Yasuhiro; Takahashi, Toshiaki
Impact of COVID-19 on early identification of protein-energy malnutrition in the cancer care setting: a repeated cross-sectional survey of cancer care professionals

新型冠状病毒肺炎对肿瘤诊疗环境中蛋白质-能量营养不良早期识别的影响：一项针对肿瘤护理专业人员的重复横断面调查

Supportive Care in Cancer
IF3
2026-01-220
OAAI
Marianne Boll Kristensen; Megan Crichton; Wolfgang Marx; Tateaki Naito; Egidio Del Fabbro; Elizabeth Isenring; Skye Marshall
Initial Patient Characteristics Associated With Ineligibility for Second-Line Therapy After Progression on First-Line Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer

EGFR突变非小细胞肺癌患者在使用奥希替尼一线治疗后进展，与二线治疗不适用相关的初始患者特征

THORACIC CANCER
IF2.3
2025-11-170
OAAI
Kodama, Hiroaki; Murakami, Haruyasu; Mamesaya, Nobuaki; Kobayashi, Haruki; Wakuda, Kazushige; Ko, Ryo; Ono, Akira; Kenmotsu, Hirotsugu; Naito, Tateaki; Shimizu, Tetsuo; Gon, Yasuhiro; Takahashi, Toshiaki
Phase II study of afatinib for advanced non-small cell lung cancer with uncommon epidermal growth factor receptor mutations, including compound mutations detected by next-generation sequencing

II期研究：阿法替尼治疗携带罕见表皮生长因子受体突变（包括由下一代测序检测到的复合突变）的晚期非小细胞肺癌

international journal of oncology
IF2.8
2025-07-060
PRE
Nobuaki Mamesaya; Keita Mori; Haruki Kobayashi; Shota Omori; Ryo Ko; Kazushige Wakuda; Akira Ono; Hirotsugu Kenmotsu; Tateaki Naito; Haruyasu Murakami; Toshiaki Takahashi
A phase II study of ME2136 (Asenapine Maleate) plus standard antiemetic therapy for patients, including diabetic patients, receiving cisplatin-based chemotherapy

ME2136 (马来酸阿塞那平) 加标准止吐治疗的II期研究，用于接受基于顺铂的化疗的患者，包括糖尿病患者

INVESTIGATIONAL NEW DRUGS
IF2.7
2024-10-260
PRE
Hamauchi, Satoshi; Yasui, Hirofumi; Yokota, Tomoya; Tsushima, Takahiro; Fushiki, Kunihiro; Naito, Tateaki; Ono, Akira; Kado, Nobuhiro; Onozawa, Yusuke; Murakami, Haruyasu; Takahashi, Toshiaki; Hirashima, Yasuyuki; Mori, Keita; Yamazaki, Kentaro
Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care-an international Delphi study

支持性护理2030运动: 统一全球卓越癌症支持性护理的雄心-一项国际德尔菲研究

ECLINICALMEDICINE
IF10
2024-10-011
OAAI
Chan, Raymond Javan; Knowles, Reegan; Ashbury, Fredrick D.; Bowen, Joanne; Chan, Alexandre; Chin, Melissa; Olver, Ian; Taylor, Carolyn; Tinianov, Stacey; Alberti, Paola; Bossi, Paolo; Brito-Dellan, Norman; Cooksley, Tim; Crawford, Gregory Brian; Dixit, Niharika; Fitch, Margaret I.; Freedman, Jason L.; Ginex, Pamela K.; Hart, Nicolas H.; Hertz, Daniel L.; Jefford, Michael; Koczwara, Bogda; Naito, Tateaki; Orsey, Andrea Dahlman; Ruhlmann, Christina H.; Tsoukalas, Nikolaos; van den Hurk, Corina; Van Sebille, Ysabella; Wardill, Hannah Rose; Scotte, Florian; Lustberg, Maryam
Efficacy and safety of ponsegromab, a first-in-class, monoclonal antibody inhibitor of growth differentiation factor 15, in patients with cancer cachexia: A randomized, placebo-controlled, phase II study

庞塞格罗玛单抗（ponsegromab）的疗效和安全性评估：该药物为一种首创的单克隆抗体抑制剂，可抑制生长分化因子15，用于癌症恶病质患者的研究：一项随机、安慰剂对照的II期临床试验

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Crawford, J.; Groarke, J. D.; Collins, S. M.; Lubaczewski, S.; Roeland, E. J.; Naito, T.; Hendifar, A. E.; Fallon, M. T.; Takayama, K.; Asmis, T. R.; Dunne, R. F.; Rossulek, M.; Qiu, R.; Saxena, A. R.
Effect of polypharmacy on the outcomes of older patients with advanced non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors: A retrospective cohort study

多重用药对PD-1/PD-L1抑制剂治疗老年晚期非小细胞肺癌患者预后的影响: 一项回顾性队列研究

JOURNAL OF GERIATRIC ONCOLOGY
IF2.7
2024-09-010
PRE
Morikawa, Noboru; Naito, Tateaki; Morita, Meiko; Sekikawa, Motoki; Doshita, Kosei; Yabe, Michitoshi; Kodama, Hiroaki; Miura, Keita; Iida, Yuko; Mamesaya, Nobuaki; Kobayashi, Haruki; Ko, Ryo; Wakuda, Kazushige; Ono, Akira; Kenmotsu, Hirotsugu; Murakami, Haruyasu; Takahashi, Toshiaki
The barriers to interprofessional care for cancer cachexia among Japanese healthcare providers: A nationwide survey

日本医疗保健提供者对癌症恶病质进行跨专业护理的障碍: 一项全国性调查

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
IF9.1
2023-11-285
OAAI
Naito, Tateaki; Wakabayashi, Hidetaka; Aso, Sakiko; Konishi, Masaaki; Saitoh, Masakazu; Baracos, Vickie E.; Coats, Andrew J.; Anker, Stefan D.; Sherman, Lawrence; Klompenhouwer, Tatiana; Shirotani, Noriyasu; Inui, Akio; Arai, Hidenori

研究方向

暂未获取到该数据
T
Toshiaki Takahashi
H 指数:55论文数:653被引数:1.4万
H
Hirotsugu Kenmotsu
H 指数:41论文数:504被引数:8,043
H
Haruyasu Murakami
H 指数:49论文数:507被引数:9,275
A
Akira Ono
H 指数:36论文数:296被引数:4,799
K
Kazushige Wakuda
H 指数:30论文数:189被引数:2,561
S
Shota Omori
H 指数:23论文数:133被引数:1,544
M
Masahiro Endo
H 指数:60论文数:846被引数:1.5万
H
Haruki Kobayashi
H 指数:22论文数:206被引数:1,463
N
Nobuaki Mamesaya
H 指数:19论文数:179被引数:984
K
Keita Mori
H 指数:44论文数:372被引数:6,458